IMRT Used Less in Black Prostate Cancer Patients

IMRT Used Less in Black Prostate Cancer Patients

African Americans are less likely than Caucasians to receive intensity-modulated radiation therapy (IMRT) for localized prostate cancer (PCa), according to a study published...

Prostate Cancer Metastasis Risk Higher in Some AS Patients

Prostate Cancer Metastasis Risk Higher in Some AS Patients

Metastases develop in a small proportion of patients placed on active surveillance (AS) for prostate cancer (PCa), but the risk is significantly higher in some men than others,...

Genomic Prostate Score Predicts PCa Recurrence, Adverse Pathology

Genomic Prostate Score Predicts PCa Recurrence, Adverse Pathology

Genomic Prostate Score (GPS), a 17-gene molecular assay, strongly and independently predicts adverse pathology and time to biochemical recurrence in men with low- to...

Family History Does Not Predict Aggressive Prostate Cancer

Family History Does Not Predict Aggressive Prostate Cancer

Men with a positive family history of prostate cancer (PCa) have an increased risk of low-grade but not aggressive PCa, according to a new study. Marco Randazzo, MD, of the...

Delaying Prostate Cancer Surgery Safe in Low-Risk Patients

Delaying Prostate Cancer Surgery Safe in Low-Risk Patients

Men with low-risk prostate cancer (PCa) in the United States can delay undergoing radical prostatectomy (RP) for up to 12 months after their cancer diagnosis without...

Gleason Score Predicts BCR in High-Risk Prostate Cancer Patients

Gleason Score Predicts BCR in High-Risk Prostate Cancer Patients

Pathologic Gleason score predicts the risk of biochemical recurrence (BCR) of prostate cancer (PCa) among patients found to have positive surgical margins after radical...

Recent Developments in Prostate Cancer Management

Recent Developments in Prostate Cancer Management

David F. Penson, MD, MPH, is Professor and Chair of the Department of Urologic Surgery at Vanderbilt University Medical Center in Nashville, Tenn. He is director of the Center...

Simpler Prostate Cancer Grading System Proposed

Simpler Prostate Cancer Grading System Proposed

A consensus panel of experts has proposed a new and simpler prostate cancer grading system that could help clinicians give patients a better understanding of their...

Study Independently Validates New Prostate Cancer Grading System

Study Independently Validates New Prostate Cancer Grading System

Researchers have independently validated a proposed new grade-group system for predicting prostate cancer (PCa) outcomes, according to a new report published online ahead of...

High-Grade Prostate Cancer More Likely To Be Found in Sicker Men

High-Grade Prostate Cancer More Likely To Be Found in Sicker Men

SAN DIEGO—Multiple comorbidities at the time of a prostate cancer (PCa) diagnosis is associated with higher biopsy Gleason scores, independent of age, according to study...

Baseline PSA at Age 55-60 Predicts Prostate Cancer Risk

Baseline PSA at Age 55-60 Predicts Prostate Cancer Risk

SAN DIEGO—Baseline PSA levels in men aged 55–60 years strongly predict the future risk of being diagnosed with prostate cancer (PCa), researchers reported at the American...

Prostate Cancer Patients Taking Statins Lived Longer

Prostate Cancer Patients Taking Statins Lived Longer

HealthDay News — Statins may help lower mortality in patients with 4 common types of cancer, according to a study presented at the European Society of Cardiology's Frontiers in...